uniQure N.V. Share Price
NASDAQ: QURE | Small CapuniQure N.V. Stock Performance
uniQure N.V. Share Price Today
As of 9 October 2026, uniQure N.V.'s share price is $22.52. The stock opened at $22.95, compared to its previous close of $23.17. During today's trading session, uniQure N.V.'s share price traded between $21.70 and $22.95, with an average price of $22.32. Over the past 52 weeks, the stock has recorded a high of $71.49 and a low of $8.74. In terms of performance, uniQure N.V.'s share price has risen by 12.91% over the last six months and is down 66.73% on a year-on-year basis.
uniQure N.V. Share Price Chart
uniQure N.V. Quarterly Profit & Loss
All figures in USD
uniQure N.V. Annual Profit & Loss
All figures in USD
About uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases. Its program and pipeline involves: Huntington's Disease, Temporal Lobe Epilepsy (TLE), Fabry Disease, ALS (SOD1), Hemophilia B, Clinical Trials, and Research Programs.
uniQure N.V. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $24.16 | $22.49 | -6.56% |
Sep 2026 | $48.70 | $24.07 | -51.40% |
Aug 2026 | $43.19 | $49.53 | +13.47% |
Jul 2026 | $46.15 | $43.65 | -5.16% |
Jun 2026 | $27.66 | $46.02 | +61.43% |
May 2026 | $19.84 | $28.51 | +42.94% |
Apr 2026 | $17.53 | $19.95 | +22.06% |
Mar 2026 | $9.22 | $16.34 | +4.91% |
Feb 2026 | $22.67 | $15.57 | -31.45% |
Jan 2026 | $23.91 | $22.72 | -4.90% |
Dec 2025 | $26.64 | $23.89 | -13.03% |
Nov 2025 | $23.05 | $27.47 | -59.41% |